VM
BIOA

Valor Management’s BioAge Labs BIOA Stock Holding History

Valor Management’s Portfolio BIOA Stock Details BIOA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$229K Hold
13,105
– – 0.13% 5
2025
Q4 		$173K Hold
13,105
– – 0.31% 3
2025
Q3 		$77.1K Hold
13,105
– – 0.11% 4
2025
Q2 		$54.1K Hold
13,105
– – 0.02% 4
2025
Q1 		$49.3K Hold
13,105
– – 0.02% 4
2024
Q4 		$75.9K Hold
13,105
– – 0.03% 4
2024
Q3 		$273K Buy
+13,105
New +$263K 0.06% 4

Other funds holding BIOA

ACM
AH Capital Management Menlo Park, California $1.29B AUM 26.81% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
OCA
Octagon Capital Advisors New York $904M AUM 737.04% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return

Valor Management's BIOA Position: Q1 2026 in Review

Valor Management held its BioAge Labs (BIOA) position steady in Q1 2026 at 13,105 shares worth $229K. The position accounts for 0.13% of the portfolio, ranked #5.

Valor Management first reported a position in BIOA in Q3 2024 and has held it in 7 quarters since. The position peaked at $273K in Q3 2024. 144 funds tracked by Wall St. Rank hold BIOA as of Q1 2026.

  • Valor Management held 13,105 shares of BioAge Labs worth $229K as of Q1 2026.
  • Valor Management left its BioAge Labs share count unchanged in Q1 2026.
  • BioAge Labs made up 0.13% of Valor Management's portfolio in Q1 2026, its #5 holding.
  • Valor Management first reported a position in BioAge Labs in Q3 2024 and has held it in 7 quarters since.
  • Valor Management's BioAge Labs position peaked at $273K in Q3 2024.
  • 144 funds tracked by Wall St. Rank held BioAge Labs as of Q1 2026.

Based on Valor Management's 13F filing for Q1 2026, filed 13 May 2026.